The purpose of this study is to see if blood and bone marrow samples can be tested in a timely manner for markers that could guide cancer treatment. The testing will look for markers that specific treatments may target. Based on your test results, you will have the option to join a myeloMATCH treatment substudy for treatment or receive standard of care treatment from your doctor.
Learn more about the MyeloMATCH MSRP trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
